Association Between Secondary Botulinum Toxin A Treatment Failure in Cosmetic Indication and Anti-Complexing Protein Antibody Production

INTRODUCTION: Botulinum toxin A (BoT/A) treatment failure (BTF) affects patients subjected to repeated BoT/A exposure for cosmetic indications. BoT/A’s general formulation contains core BoT/A and complexing proteins. BTF may be caused by antibody-induced treatment failure. Antibodies against core Bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wanitphakdeedecha, Rungsima, Kantaviro, Watsachon, Suphatsathienkul, Panittra, Tantrapornpong, Ploypailin, Yan, Chadakan, Apinumtham, Chalermkwan, Srinoulprasert, Yuttana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367960/
https://www.ncbi.nlm.nih.gov/pubmed/32445175
http://dx.doi.org/10.1007/s13555-020-00397-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367960/
https://www.ncbi.nlm.nih.gov/pubmed/32445175
http://dx.doi.org/10.1007/s13555-020-00397-5

Ejemplares similares